MedCity News June 8, 2023
Dr. Joel Diamond

By continuing an open discussion on precision medicine and precision care, we can truly accelerate pharmacogenomic testing to its full potential and focus on providing the highest quality care to those who need it most.

Recently, I saw a patient concerned about their family history of colon cancer. As a family physician familiar with genetics, I obtained a thorough family history and discussed the potential for Lynch Syndrome, the most common cause of hereditary colorectal cancer. I recognized the need for better electronic medical record support for documenting a family pedigree, as well as the need for more decision support in recognizing a condition that can be detected early with appropriate screening. Lynch syndrome increases an individual’s risk of developing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Physician, Precision Medicine, Provider
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article